Abstract:An important application of CRISPR interference (CRISPRi) technology is for identifying chemical-genetic interactions (CGIs). Discovery of genes that interact with exposure to antibiotics can yield insights to drug targets and mechanisms of action or resistance. The objective is to identify CRISPRi mutants whose relative abundance is suppressed (or enriched) in the presence of a drug when the target protein is depleted, reflecting synergistic behavior. Different sgRNAs for a given target can induce a wide range of protein depletion and differential effects on growth rate. The effect of sgRNA strength can be partially predicted based on sequence features. However, the actual growth phenotype depends on the sensitivity of cells to depletion of the target protein. For essential genes, sgRNA efficiency can be empirically measured by quantifying effects on growth rate. We observe that the most efficient sgRNAs are not always optimal for detecting synergies with drugs. sgRNA efficiency interacts in a non-linear way with drug sensitivity, producing an effect where the concentration-dependence is maximized for sgRNAs of intermediate strength (and less so for sgRNAs that induce too much or too little target depletion). To capture this interaction, we propose a novel statistical method called CRISPRi-DR (for Dose-Response model) that incorporates both sgRNA efficiencies and drug concentrations in a modified dose-response equation. We use CRISPRi-DR to re-analyze data from a recent CGI experiment in to identify genes that interact with antibiotics. This approach can be generalized to non-CGI datasets, which we show via an CRISPRi dataset for growth on different carbon sources. The performance is competitive with the best of several related analytical methods. However, for noisier datasets, some of these methods generate far more significant interactions, likely including many false positives, whereas CRISPRi-DR maintains higher precision, which we observed in both empirical and simulated data.

Improved prediction of bacterial CRISPRi guide efficiency from depletion screens through mixed-effect machine learning and data integration

CRSIPR-A-I: a webtool for the efficacy prediction of CRISPR activation and interference

Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches

Machine learning methods for predicting guide RNA effects in CRISPR epigenome editing experiments

Leveraging uncertainty quantification to optimise CRISPR guide RNA selection

Improved sgRNA design in bacteria via genome-wide activity profiling

A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens

Unified Model to Predict gRNA Efficiency across Diverse Cell Lines and CRISPR-Cas9 Systems

Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning

Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR

Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and -Cas12a guides in Yarrowia lipolytica

Prediction of activity of CRISPR-Cpf1 guide RNA via in vivo high-throughput screening

CRISPR–Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning

A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action

Prediction of Off-Target Specificity and Cell-Specific Fitness of CRISPR-Cas System Using Attention Boosted Deep Learning and Network-Based Gene Feature.

Evaluation of efficiency prediction algorithms and development of ensemble model for CRISPR/Cas9 gRNA selection

Deep sampling of gRNA in the human genome and deep-learning-informed prediction of gRNA activities

Balanced Training Sets Improve Deep Learning-Based Prediction of CRISPR sgRNA Activity

Sequence determinants of improved CRISPR sgRNA design

DeepCRISTL: Deep transfer learning to predict CRISPR/Cas9 on-target editing efficiency in specific cellular contexts